GoLiver Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
M&A
- (Upcoming)
- Investors
-
13
GoLiver Therapeutics General Information
Description
Developer of regenerative drugs intended to treat liver diseases without transplantation using differentiated pluripotent stem cells. The company engages in formulating regenerative drug candidates consisting of frozen allogeneic liver cells for the treatment of acute and chronic severe liver failure without the need for organ transplants, enabling businesses to use therapeutic options instead of transplants.
Contact Information
Website
www.golivertx.comCorporate Office
- 8 Quai Moncousu
- BP 70721
- 44000 Nantes
- France
Corporate Office
- 8 Quai Moncousu
- BP 70721
- 44000 Nantes
- France
GoLiver Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | Upcoming | Generating Revenue | ||||
| 8. Later Stage VC | 25-Sep-2024 | Completed | Generating Revenue | |||
| 7. Grant | 18-Mar-2021 | Completed | Generating Revenue | |||
| 6. Grant | 17-Jun-2020 | Completed | Generating Revenue | |||
| 5. Seed Round | 27-Aug-2019 | Completed | Generating Revenue | |||
| 4. Corporate | 30-Apr-2019 | Completed | Generating Revenue | |||
| 3. Seed Round | 11-Jun-2018 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Spin-Off | 01-Apr-2017 | Completed | Generating Revenue |
GoLiver Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| C shares | ||||||||
| A Shares | ||||||||
| C shares | ||||||||
| C shares | 14,356 | $0.111001 | $18.17 | $18.17 | 1x | $18.17 | 3.35% | |
| C shares | 66,098 | $0.111001 | $22.2 | $22.2 | 1x | $22.2 | 15.44% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
GoLiver Therapeutics Patents
GoLiver Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021233179-A1 | Hepatic stem-like cells for the treatment and/or the prevention of fulminant liver disorders | Pending | 13-Mar-2020 | ||
| CA-3170705-A1 | Hepatic stem-like cells for the treatment and/or the prevention of fulminant liver disorders | Pending | 13-Mar-2020 | ||
| EP-4118187-A1 | Hepatic stem-like cells for the treatment and/or the prevention of fulminant liver disorders | Pending | 13-Mar-2020 | ||
| WO-2021180984-A1 | Hepatic stem-like cells for the treatment and/or the prevention of fulminant liver disorders | Inactive | 13-Mar-2020 | ||
| US-20230407264-A1 | Hepatic stem-like cells for the treatment and/or the prevention of liver disorders | Inactive | 13-Mar-2020 | C12N5/0672 |
GoLiver Therapeutics Signals
GoLiver Therapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Government of Francaise | Government | |||
| Bpifrance | Sovereign Wealth Fund | |||
| European Union | Government | |||
| Developcentre | Venture Capital | Minority | ||
| SC Carat Patrimoine | Venture Capital | Minority |
GoLiver Therapeutics FAQs
-
When was GoLiver Therapeutics founded?
GoLiver Therapeutics was founded in 2017.
-
Where is GoLiver Therapeutics headquartered?
GoLiver Therapeutics is headquartered in Nantes, France.
-
What is the size of GoLiver Therapeutics?
GoLiver Therapeutics has 10 total employees.
-
What industry is GoLiver Therapeutics in?
GoLiver Therapeutics’s primary industry is Drug Discovery.
-
Is GoLiver Therapeutics a private or public company?
GoLiver Therapeutics is a Private company.
-
What is GoLiver Therapeutics’s current revenue?
The current revenue for GoLiver Therapeutics is .
-
How much funding has GoLiver Therapeutics raised over time?
GoLiver Therapeutics has raised $4.01M.
-
Who are GoLiver Therapeutics’s investors?
Government of Francaise, Bpifrance, European Union, Developcentre, and SC Carat Patrimoine are 5 of 13 investors who have invested in GoLiver Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process